Expression of Lysyl Oxidase-Related Protein and Effect of Lysyl Oxidase Inhibition in Cyclosporine-Induced Nephropathy Mouse Model
Pharmaceuticals · 21.06.2026 · 19 (6) · 960
DOI: 10.3390/ph19060960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 21.06.2026. Verfasst von Hyo Jeong Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Health Insurance Service Medical Center, Ilsan Hospital, 100 Ilsan-ro, Goyang 10444, Republic of Korea. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Korean Society of Nephrology, Faculty Research Grant of Yonsei University College of Medicine.
Abstract (Originalsprache)
Background/Objectives Lysyl oxidase-like 2 (LOXL2), a member of the lysyl oxidase family of amine oxidases involved in collagen cross-linking, has emerged as a key mediator of pathological extracellular matrix remodeling and tissue fibrosis. Dysregulated LOXL2 activity has been implicated in various fibrotic diseases; however, its role in fibrosis-driven chronic kidney injury, particularly in the context of calcineurin inhibitor-induced kidney toxicity, remains incompletely defined.
Methods
To investigate the contribution of LOXL2 inhibitor to cyclosporine A (CsA)-induced nephropathy, a well-established model of progressive tubulointerstitial fibrosis, male CD-1 mice were administered either saline or CsA (15 mg/kg/day, intraperitoneally) for 8 weeks. After 4 weeks of CsA exposure, CsA-treated mice were further divided into two groups and received either vehicle or a LOXL2 inhibitor (10 mg/kg/day, oral gavage) for an additional 4 weeks. Kidney function, albuminuria, histological fibrosis, inflammatory cell infiltration, and profibrotic gene expression were assessed.
Results
In a murine model of CsA-induced nephropathy, pharmacological inhibition of LOXL2 markedly improved kidney outcomes. LOXL2 inhibition significantly reduced albuminuria and ameliorated kidney dysfunction. In parallel, tubulointerstitial fibrosis was substantially attenuated, accompanied by reduced myofibroblast activation and extracellular matrix accumulation. These protective effects were associated with downregulation of profibrotic and inflammatory mediators and inhibition of TGF-β-related downstream signaling pathways activated by CsA.
Conclusions
The present preclinical findings suggest that Compound #765-mediated LOXL2 inhibition may offer a potential therapeutic benefit in CsA-induced fibrosis, though further validation is warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, National Health Insurance Service Medical Center, Ilsan Hospital, 100 Ilsan-ro, Goyang 10444, Republic of Korea.
- Division of Nephrology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Republic of Korea.
- Severance Institute for Vascular and Metabolic Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Microbiology and Immunology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
ORCID-Profile: Hyo Jeong Kim, Hoon Young Choi, Jae Myun Lee, Hyeong Cheon Park
Förderung
- The Korean Society of Nephrology
- Faculty Research Grant of Yonsei University College of Medicine
Zitieren
APA
Kim, H. J., Kim, T. Y., Jhee, J. H., Choi, H. Y., Lee, J. M., & Park, H. C. (2026). Expression of Lysyl Oxidase-Related Protein and Effect of Lysyl Oxidase Inhibition in Cyclosporine-Induced Nephropathy Mouse Model. Pharmaceuticals, 19(6), 960. https://doi.org/10.3390/ph19060960
Vancouver
Kim HJ, Kim TY, Jhee JH, Choi HY, Lee JM, Park HC. Expression of Lysyl Oxidase-Related Protein and Effect of Lysyl Oxidase Inhibition in Cyclosporine-Induced Nephropathy Mouse Model. Pharmaceuticals. 2026;19(6):960. doi:10.3390/ph19060960
BibTeX
@article{Kim2026,
author = {Kim, Hyo Jeong and Kim, Tae Yeon and Jhee, Jong Hyun and Choi, Hoon Young and Lee, Jae Myun and Park, Hyeong Cheon},
title = {Expression of Lysyl Oxidase-Related Protein and Effect of Lysyl Oxidase Inhibition in Cyclosporine-Induced Nephropathy Mouse Model},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {960},
doi = {10.3390/ph19060960}
}
EUVIMED